Patents by Inventor Erik Robert Sampson

Erik Robert Sampson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-2 muteins and uses thereof
    Patent number: 11965008
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: July 27, 2021
    Date of Patent: April 23, 2024
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 muteins and uses thereof
    Patent number: 11945852
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: July 26, 2021
    Date of Patent: April 2, 2024
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 muteins and uses thereof
    Patent number: 11779632
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: March 15, 2021
    Date of Patent: October 10, 2023
    Assignee: PANDION OPERATION, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20220195003
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: July 27, 2021
    Publication date: June 23, 2022
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20220185859
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: July 26, 2021
    Publication date: June 16, 2022
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20220031808
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: March 15, 2021
    Publication date: February 3, 2022
    Inventors: Nathan HIGGINSON-SCOTT, Joanne L. VINEY, Jyothsna VISWESWARAIAH, Erik Robert SAMPSON, Kevin Lewis OTIPOBY
  • TARGETED IMMUNOTOLERANCE
    Publication number: 20210277085
    Abstract: Methods and compounds for conferring site-specific or local immune privilege.
    Type: Application
    Filed: November 20, 2018
    Publication date: September 9, 2021
    Applicant: Pandion Therapeutics, Inc.
    Inventors: Nathan HIGGINSON-SCOTT, Joanne L. VINEY, Jyothsna VISWESWARAIAH, Erik Robert SAMPSON, Kevin Lewis OTIPOBY
  • IL-2 muteins and uses thereof
    Patent number: 11091527
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: November 25, 2019
    Date of Patent: August 17, 2021
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 muteins and uses thereof
    Patent number: 11091526
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: November 25, 2019
    Date of Patent: August 17, 2021
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 muteins and uses thereof
    Patent number: 10946068
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: March 16, 2021
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20200325201
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: November 25, 2019
    Publication date: October 15, 2020
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20200325202
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: November 25, 2019
    Publication date: October 15, 2020
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20190321446
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: November 28, 2018
    Publication date: October 24, 2019
    Inventors: Nathan HIGGINSON-SCOTT, Joanne L. VINEY, Jyothsna VISWESWARAIAH, Erik Robert SAMPSON, Kevin Lewis OTIPOBY
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20190169255
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: December 21, 2018
    Publication date: June 6, 2019
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20190169254
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: December 21, 2018
    Publication date: June 6, 2019
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 muteins
    Patent number: 10174091
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: January 8, 2019
    Assignee: Pandion Therapeutics, Inc.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 muteins
    Patent number: 10174092
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: January 8, 2019
    Assignee: Pandion Therapeutics, Inc.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby